曹磊;纪方;蔡晓冰;唐昊;竺伟;张瑞;

• 1:第二军医大学长海医院

摘要(Abstract)：

[目的]运用基因芯片技术探索骨肉瘤发病及转移相关基因,研究基因表达水平对于骨肉瘤发生及转移的重要意义。[方法]采用2个公认的骨肉瘤细胞株及1个成骨细胞株,提取总RNA,合成生物素标记的cRNA与SBC基因芯片杂交。随机挑选4个差异表达基因,分别设计合成引物,用嵌合荧光法(SYBR Green Ⅰ)实时RT-PCR法定量测量术中收集的新鲜骨肉瘤标本及两株细胞中各基因的表达水平,应用ABI Prism 7 300分析其与成骨细胞株之间的表达差异。[结果]以表达差异≥2.0或≤0.5倍为限,在SBC芯片包含的所有基因(约15 000个转录本)中,2个骨肉瘤细胞株与成骨细胞株相比较,共同上调189个基因;共同下调84个基因。随机挑选4个差异表达基因的实时RT-PCR结果与芯片结果完全相符。[结论]骨肉瘤是一种多基因病变,应用基因芯片技术有助于发现该肿瘤的基因变化规律。

关键词(KeyWords)： 骨肉瘤;基因微矩阵;基因

Abstract:

Keywords:

基金项目(Foundation): 上海市科委基金资助项目(编号:64119605)

作者(Author): 曹磊;纪方;蔡晓冰;唐昊;竺伟;张瑞;

Email:

DOI:

参考文献(References)：

• [1]Sooryanarayana V,Le H,et al.Defining aggressive prostate cancer u-sing a 12-gene model[J].Neoplasia,2006,8:59-68.
• [2]Pamela L P,Matthias DH,et al.Genomic profiling of hormone-na velymph node metastases in patients with prostate cancer[J].Neopla-sia,2006,8:1083-1089.
• [3]Marci E S,Ben D,et al.Variation in gene expression patterns in effu-sions and primary tumors from serous ovarian cancer patients[J].MolCancer,2005,4:26.
• [4]曾恒,陈安民,李锋,等.骨肉瘤诱导分化与多药耐药表型的生物学性状比较[J].中国矫形外科杂志,2007,15:1019-1022.
• [5]Yan L,Yijun Y,et al.Common human cancer genes discovered by In-tegrated gene-expression analysis[J].Plos One,2007,2:1149.
• [6]Kornelia P.Breast cancer:origins and evolution[J].J Clin Ivest,2007,11:3155-3163.
• [7]Ena W,Monica C,Panelli,et al.Melanoma-restricted genes[J].JTransl Med,2004,2:34.
• [8]Joseph Z,Zaretsky,Itay Barnea,et al.MUC1 gene overexpressed inbreast cancer:structure and transcriptional activity of the MUC1 pro-moter and role of estrogen receptor alpha(ERα)in regulation of theMUC1 gene expression[J].Mol Cancer,2006,5:57.
• [9]Kepal N,Patel,Ellie M,et al.MUC1 plays a role in tumor mainte-nance in aggressive thyroid carcinomas[J].PMC,2007,27.
• [10]Timothy JD,Nicholas FSW,et al.The role of MUC1 and MUC3 in thebiology and prognosis of colorectal cancer[J].World J Surg Oncol,2007,5:31.
• [11]Zucchi I,Mento E,Kuznetsov VA,et al.Gene expression profiles ofepithelial cells microscopically isolated from a breast-invasive ductalcarcinoma and a nodal metastasis[J].Proc Natl Acad Sci U S A,2004,28:18147-18152.
• [12]Grant A,Darnell,Toni M,et al.Inhibition of retinoblastoma proteindegradation by interaction with the serpin plasminogen activator inhibi-tor 2 via a novel consensus motif[J].Mol Cell Biol,2003,23:6520-6532.
• [13]Stephanie L,Rellick,et al.Cellular pyrin domain-only protein 2 is acandidate regulator of inflammasome activation[J].Infect Immun,2007,75:1484-1492.